|
시장보고서
상품코드
1786829
세계의 POC 지질 검사 시장 : 규모, 점유율, 동향, 산업 분석 보고서 - 제품별, 용도별, 적응 질환별, 최종 용도별, 지역별 시장 예측(2025-2034년)Point of Care Lipid Test Market Size, Share, Trends, Industry Analysis Report By Product (Instruments, Consumables), By Application, By Disease Indication, By End Use, By Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면 POC 지질 검사 시장 규모는 2034년까지 13억 9,297만 달러에 이를 전망입니다. 이 설문조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.
POC 지질 검사는 총 콜레스테롤, HDL, LDL, 트리글리세라이드와 같은 지질 값을 환자의 진료 현장에서 직접 측정하는 데 사용되는 진단 도구입니다. 소량의 혈액 샘플을 사용하면 대부분의 경우 몇 분 이내에 중앙 실험실이 필요없는 신속한 결과를 얻을 수 있습니다.
정부와 보건기구는 심장병 감소를 목표로 한 국민 보건 프로그램의 일환으로 일상적인 콜레스테롤 스크리닝을 추진하고 있습니다. 많은 공중 보건 캠페인은 특히 비만, 당뇨병, 심혈관 질환의 가족력과 같은 위험 인자를 가진 사람들에게 조기 발견과 정기적인 지질 검사를 강조합니다. 일부 국가에서는 지역 클리닉과 약국에서 POC 검사에 자금과 인센티브를 제공하는 곳도 있습니다. 이러한 노력은 집단 전체에서 POC 지질 검사의 정상화와 이용 증가에 도움이 됩니다. 강력한 정책 지원과 자금 제공은 시장 성장 및 접근성을 더욱 가속화합니다.
질병을 조기에 발견하거나 완전히 회피하는 것을 목표로 하는 반응 의료에서 예방 의료로의 전환이 진행되고 있습니다. 지질 검사는 증상이 나타나기 전에 심장 질환과 관련 질병의 위험을 확인하는 중요한 도구입니다. POC 검사 장비는 이 프로세스를 보다 빠르고 용이하게 하고, 특히 고위험군에서 보다 빈번한 검사를 촉진합니다. 이 검사는 조기 개입과 생활 습관의 개선을 허용함으로써 더 나은 건강 결과를 지원합니다. 환자 및 의료 제공업체 사이에서 예방 의료에 대한 의식이 높아짐에 따라 간편한 지질 검사 옵션에 대한 수요가 크게 증가하고 있으며, POC 지질 검사 시장의 성장을 견인하고 있습니다.
POC 지질 검사 시장 보고서 하이라이트
2024년 소모품 부문은 최대 점유율을 차지했으며, 이러한 항목은 모든 검사에 필수적이며 정기적으로 교체해야 하므로 일관된 수요를 추진하고 있습니다.
비만률이 증가함에 따라 고트리글리세리드 혈증이 점차 흔해지고 있기 때문에 고트리글리세리드 혈증 부문이 예측 기간 동안 큰 성장을 기대할 수 있습니다.
북미 시장은 심혈관 질환의 유병률 상승, 고령화, 정비된 의료 인프라에 견인되어 2024년 최대 점유율을 차지했습니다.
아시아태평양 시장은 심혈관 질환 환자 증가, 건강 의식 증가, 의료 서비스에 대한 액세스 확대를 배경으로 예측 기간 동안 크게 성장할 것으로 예측됩니다.
세계 주요 시장 기업으로는 Abbott Laboratories, Callegari Srl, F. Hoffmann-La Roche Ltd., Menarini Group, MiCoBio, Nova Biomedical, SD Biosensor, Inc. 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 POC 지질 검사 시장 인사이트
- 시장 현황
- POC 지질 검사 시장 역학
- 성장 촉진요인 및 기회
- 고령화 사회
- 심혈관 질환의 유병률 상승
- 성장 억제요인 및 과제
- 높은 초기 투자액
- 성장 촉진요인 및 기회
- PESTEL 분석
- POC 지질 검사 시장 동향
- 밸류체인 분석
제5장 세계의 POC 지질 검사 시장 : 제품별
- 주요 조사 결과
- 서문
- 기기
- 소모품
제6장 세계의 POC 지질 검사 시장 : 용도별
- 주요 조사 결과
- 서문
- 고지혈증
- 고트리글리세리드혈증
- 탄지에르병
- 고리포단백혈증
- 가족성 고콜레스테롤혈증
- 기타
제7장 세계의 POC 지질 검사 시장 : 적응 질환별
- 주요 조사 결과
- 서문
- 지질 및 리포단백질 질환
- 동맥경화증
- 간 및 신장 질환
- 당뇨병
- 기타
제8장 세계의 POC 지질 검사 시장 : 최종 용도별
- 주요 조사 결과
- 서문
- 병원
- 클리닉
- 연구 및 진단 실험실
- 기타
제9장 세계의 POC 지질 검사 시장 : 지역별
- 주요 조사 결과
- 서문
- POC 지질 검사 시장 분석 : 지역별(2020-2034년)
- 북미
- 북미 : 제품별(2020-2034년)
- 북미 : 용도별(2020-2034년)
- 북미 : 질환별(2020-2034년)
- 북미 : 최종 용도별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 제품별(2020-2034년)
- 유럽 : 용도별(2020-2034년)
- 유럽 : 질환별(2020-2034년)
- 유럽 : 최종 용도별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 제품별(2020-2034년)
- 아시아태평양 : 용도별(2020-2034년)
- 아시아태평양 : 질환별(2020-2034년)
- 아시아태평양 : 최종 용도별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 제품별(2020-2034년)
- 중동 및 아프리카 : 용도별(2020-2034년)
- 중동 및 아프리카 : 질환별(2020-2034년)
- 중동 및 아프리카 : 최종 용도별(2020-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 제품별(2020-2034년)
- 라틴아메리카 : 용도별(2020-2034년)
- 라틴아메리카 : 질환별(2020-2034년)
- 라틴아메리카 : 최종 용도별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제10장 경쟁 구도
- 확대 및 인수 분석
- 확대
- 인수
- 제휴, 협업, 합의 및 공개
제11장 기업 프로파일
- Abbott Laboratories
- Callegari Srl
- F. Hoffmann-La Roche Ltd.
- Menarini Group
- MiCoBio
- Nova Biomedical
- SD Biosensor, Inc.
- Sinocare Inc.
- VivaChek Biotech(Hangzhou) Co., Ltd.
The point of care (POC) lipid test market size is expected to reach USD 1,392.97 million by 2034, according to a new study by Polaris Market Research. The report "Point of Care Lipid Test Market Size, Share, Trends, Industry Analysis Report By Product (Instruments, Consumables), By Application, By Disease Indication, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
A point of care (POC) lipid test is a diagnostic tool used to measure lipid levels such as total cholesterol, HDL, LDL, and triglycerides, directly at the site of patient care. It provides rapid results from a small blood sample, often within minutes, without needing a central laboratory.
Governments and health organizations are promoting routine cholesterol screening as part of national health programs aimed at reducing heart disease. Many public health campaigns emphasize early detection and regular lipid testing, especially for people with risk factors such as obesity, diabetes, or a family history of cardiovascular conditions. Some countries further provide funding or incentives for point of care testing in community clinics and pharmacies. These efforts are helping to normalize and increase the use of POC lipid tests across populations. Strong policy support and funding further accelerate the growth and accessibility of the market.
There is a growing shift from reactive to preventive healthcare, where the goal is to catch diseases early or avoid them altogether. Lipid testing is a key tool in identifying risks for heart disease and related conditions before symptoms appear. Point of care testing devices make this process faster and easier, encouraging more frequent testing, especially in high-risk groups. These tests support better health outcomes by enabling early intervention and lifestyle changes. The demand for convenient lipid testing options is increasing significantly as awareness of preventive care rises among both patients and providers, thereby driving the POC lipid test market growth.
Point of Care Lipid Test Market Report Highlights
In 2024, the consumables segment dominated with the largest share as these items are essential for every test and need to be replaced regularly, fueling consistent demand.
The hypertriglyceridemia segment is expected to experience significant growth during the forecast period as hypertriglyceridemia is becoming increasingly common due to rising obesity rates.
The market in North America dominated with the largest share in 2024, driven by rising cardiovascular disease prevalence, an aging population, and well-established healthcare infrastructure.
The Asia Pacific market is projected to witness substantial growth during the forecast period, driven by increasing cardiovascular disease cases, growing health awareness, and expanding access to healthcare services.
A few global key market players are Abbott Laboratories; Callegari Srl; F. Hoffmann-La Roche Ltd.; Menarini Group; MiCoBio; Nova Biomedical; SD Biosensor, Inc.; Sinocare Inc.; and VivaChek Biotech (Hangzhou) Co., Ltd.
Polaris Market Research has segmented the point of care lipid test market report on the basis of product, application, disease indication, end use, and region:
By Product (Revenue - USD Million, 2020-2034)
Instruments
Consumables
By Application (Revenue - USD Million, 2020-2034)
Hyperlipidemia
Hypertriglyceridemia
Tangier Disease
Hyperlipoproteinemia
Familial Hypercholesterolemia
Others
By Disease Indication (Revenue - USD Million, 2020-2034)
Lipid and Lipoprotein Disorders
Atherosclerosis
Liver and Renal Diseases
Diabetes Mellitus
Others
By End Use (Revenue - USD Million, 2020-2034)
Hospitals
Clinics
Research and Diagnostic Laboratories
Others
By Regional Outlook (Revenue - USD Million, 2020-2034)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Point of Care Lipid Test Market Insights
- 4.1. Point of Care Lipid Test Market - Market Snapshot
- 4.2. Point of Care Lipid Test Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Ageing Population
- 4.2.1.2. Rising Prevalence of Cardiovascular Diseases
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Initial Investment
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Point of Care Lipid Test Market Trends
- 4.6. Value Chain Analysis
5. Global Point of Care Lipid Test Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 5.3. Instruments
- 5.3.1. Global Point of Care Lipid Test Market, by Instruments, by Region, 2020-2034 (USD million)
- 5.4. Consumables
- 5.4.1. Global Point of Care Lipid Test Market, by Consumables, by Region, 2020-2034 (USD million)
6. Global Point of Care Lipid Test Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 6.3. Hyperlipidemia
- 6.3.1. Global Point of Care Lipid Test Market, by Hyperlipidemia, by Region, 2020-2034 (USD million)
- 6.4. Hypertriglyceridemia
- 6.4.1. Global Point of Care Lipid Test Market, by Hypertriglyceridemia, by Region, 2020-2034 (USD million)
- 6.5. Tangier Disease
- 6.5.1. Global Point of Care Lipid Test Market, by Tangier Disease, by Region, 2020-2034 (USD million)
- 6.6. Hyperlipoproteinemia
- 6.6.1. Global Point of Care Lipid Test Market, by Hyperlipoproteinemia, by Region, 2020-2034 (USD million)
- 6.7. Familial Hypercholesterolemia
- 6.7.1. Global Point of Care Lipid Test Market, by Familial Hypercholesterolemia, by Region, 2020-2034 (USD million)
- 6.8. Others
- 6.8.1. Global Point of Care Lipid Test Market, by Others, by Region, 2020-2034 (USD million)
7. Global Point of Care Lipid Test Market, by Disease Indication
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Point of Care Lipid Test Market, by Medical Biotechnology, 2020-2034 (USD million)
- 7.3. Lipid and Lipoprotein Disorders
- 7.3.1. Global Point of Care Lipid Test Market, by Lipid and Lipoprotein Disorders, by Region, 2020-2034 (USD million)
- 7.4. Atherosclerosis
- 7.4.1. Global Point of Care Lipid Test Market, by Atherosclerosis, by Region, 2020-2034 (USD million)
- 7.5. Liver and Renal Diseases
- 7.5.1. Global Point of Care Lipid Test Market, by Liver and Renal Diseases, by Region, 2020-2034 (USD million)
- 7.6. Diabetes Mellitus
- 7.6.1. Global Point of Care Lipid Test Market, by Diabetes Mellitus, by Region, 2020-2034 (USD million)
- 7.7. Others
- 7.7.1. Global Point of Care Lipid Test Market, by Others, by Region, 2020-2034 (USD million)
8. Global Point of Care Lipid Test Market, by End Use
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 8.3. Hospitals
- 8.3.1. Global Point of Care Lipid Test Market, by Hospitals, by Region, 2020-2034 (USD million)
- 8.4. Clinics
- 8.4.1. Global Point of Care Lipid Test Market, by Clinics, by Region, 2020-2034 (USD million)
- 8.5. Research and Diagnostic Laboratories
- 8.5.1. Global Point of Care Lipid Test Market, by Research and Diagnostic Laboratories, by Region, 2020-2034 (USD million)
- 8.6. Others
- 8.6.1. Global Point of Care Lipid Test Market, by Others, by Region, 2020-2034 (USD million)
9. Global Point of Care Lipid Test Market, by Geography
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Point of Care Lipid Test Market Assessment, By Geography, 2020-2034 (USD million)
- 9.3. Point of Care Lipid Test Market - North America
- 9.3.1. North America: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.3.2. North America: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.3.3. North America: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.3.4. North America: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.3.5. Point of Care Lipid Test Market - US
- 9.3.5.1. US: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.3.5.2. US: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.3.5.3. US: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.3.5.4. US: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.3.6. Point of Care Lipid Test Market - Canada
- 9.3.6.1. Canada: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.3.6.2. Canada: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.3.6.3. Canada: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.3.6.4. Canada: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.4. Point of Care Lipid Test Market - Europe
- 9.4.1. Europe: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.4.2. Europe: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.4.3. Europe: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.4.4. Europe: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.4.5. Point of Care Lipid Test Market - UK
- 9.4.5.1. UK: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.4.5.2. UK: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.4.5.3. UK: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.4.5.4. UK: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.4.6. Point of Care Lipid Test Market - France
- 9.4.6.1. France: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.4.6.2. France: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.4.6.3. France: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.4.6.4. France: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.4.7. Point of Care Lipid Test Market - Germany
- 9.4.7.1. Germany: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.4.7.2. Germany: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.4.7.3. Germany: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.4.7.4. Germany: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.4.8. Point of Care Lipid Test Market - Italy
- 9.4.8.1. Italy: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.4.8.2. Italy: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.4.8.3. Italy: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.4.8.4. Italy: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.4.9. Point of Care Lipid Test Market - Spain
- 9.4.9.1. Spain: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.4.9.2. Spain: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.4.9.3. Spain: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.4.9.4. Spain: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.4.10. Point of Care Lipid Test Market - Netherlands
- 9.4.10.1. Netherlands: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.4.10.2. Netherlands: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.4.10.3. Netherlands: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.4.10.4. Netherlands: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.4.11. Point of Care Lipid Test Market - Russia
- 9.4.11.1. Russia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.4.11.2. Russia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.4.11.3. Russia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.4.11.4. Russia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.4.12. Point of Care Lipid Test Market - Rest of Europe
- 9.4.12.1. Rest of Europe: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.4.12.2. Rest of Europe: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.4.12.3. Rest of Europe: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.4.12.4. Rest of Europe: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.5. Point of Care Lipid Test Market - Asia Pacific
- 9.5.1. Asia Pacific: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.5.2. Asia Pacific: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.5.3. Asia Pacific: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.5.4. Asia Pacific: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.5.5. Point of Care Lipid Test Market - China
- 9.5.5.1. China: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.5.5.2. China: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.5.5.3. China: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.5.5.4. China: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.5.6. Point of Care Lipid Test Market - India
- 9.5.6.1. India: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.5.6.2. India: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.5.6.3. India: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.5.6.4. India: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.5.7. Point of Care Lipid Test Market - Malaysia
- 9.5.7.1. Malaysia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.5.7.2. Malaysia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.5.7.3. Malaysia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.5.7.4. Malaysia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.5.8. Point of Care Lipid Test Market - Japan
- 9.5.8.1. Japan: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.5.8.2. Japan: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.5.8.3. Japan: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.5.8.4. Japan: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.5.9. Point of Care Lipid Test Market - Indonesia
- 9.5.9.1. Indonesia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.5.9.2. Indonesia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.5.9.3. Indonesia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.5.9.4. Indonesia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.5.10. Point of Care Lipid Test Market - South Korea
- 9.5.10.1. South Korea: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.5.10.2. South Korea: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.5.10.3. South Korea: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.5.10.4. South Korea: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.5.11. Point of Care Lipid Test Market - Australia
- 9.5.11.1. Australia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.5.11.2. Australia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.5.11.3. Australia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.5.11.4. Australia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.5.12. Point of Care Lipid Test Market - Rest of Asia Pacific
- 9.5.12.1. Rest of Asia Pacific: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.5.12.2. Rest of Asia Pacific: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.5.12.3. Rest of Asia Pacific: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.5.12.4. Rest of Asia Pacific: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.6. Point of Care Lipid Test Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.6.2. Middle East & Africa: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.6.3. Middle East & Africa: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.6.4. Middle East & Africa: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.6.5. Point of Care Lipid Test Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.6.5.2. Saudi Arabia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.6.5.3. Saudi Arabia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.6.5.4. Saudi Arabia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.6.6. Point of Care Lipid Test Market - UAE
- 9.6.6.1. UAE: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.6.6.2. UAE: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.6.6.3. UAE: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.6.6.4. UAE: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.6.7. Point of Care Lipid Test Market - Israel
- 9.6.7.1. Israel: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.6.7.2. Israel: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.6.7.3. Israel: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.6.7.4. Israel: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.6.8. Point of Care Lipid Test Market - South Africa
- 9.6.8.1. South Africa: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.6.8.2. South Africa: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.6.8.3. South Africa: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.6.8.4. South Africa: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.6.9. Point of Care Lipid Test Market - Rest of Middle East & Africa
- 9.6.9.1. Rest of Middle East & Africa: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.6.9.2. Rest of Middle East & Africa: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.6.9.3. Rest of Middle East & Africa: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.6.9.4. Rest of Middle East & Africa: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.7. Point of Care Lipid Test Market - Latin America
- 9.7.1. Latin America: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.7.2. Latin America: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.7.3. Latin America: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.7.4. Latin America: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.7.5. Point of Care Lipid Test Market - Mexico
- 9.7.5.1. Mexico: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.7.5.2. Mexico: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.7.5.3. Mexico: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.7.5.4. Mexico: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.7.6. Point of Care Lipid Test Market - Brazil
- 9.7.6.1. Brazil: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.7.6.2. Brazil: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.7.6.3. Brazil: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.7.6.4. Brazil: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.7.7. Point of Care Lipid Test Market - Argentina
- 9.7.7.1. Argentina: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.7.7.2. Argentina: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.7.7.3. Argentina: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.7.7.4. Argentina: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
- 9.7.8. Point of Care Lipid Test Market - Rest of Latin America
- 9.7.8.1. Rest of Latin America: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
- 9.7.8.2. Rest of Latin America: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
- 9.7.8.3. Rest of Latin America: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
- 9.7.8.4. Rest of Latin America: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Abbott Laboratories
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Callegari Srl
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. F. Hoffmann-La Roche Ltd.
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Menarini Group
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. MiCoBio
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Nova Biomedical
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. SD Biosensor, Inc.
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Sinocare Inc.
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. VivaChek Biotech (Hangzhou) Co., Ltd.
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
